Objective: Connectors are frequently and necessarily used in patients undergoing intravenous fluid therapy. All of the catheters and connectors may be a risk factor for catheter infections if aseptic techniques were not used. This study was conducted to determine the effect of 3-way stopcock (3WSC) and Split Septum Injection Valve (SSIV) Usage on peripheral intravenous catheter colonization and infection. Material and Methods: This is a quasi-experimental study. The sample of the study consists of 216 patients (108 control, and 108 experimental group). 3WSC was integrated to the control group and SSIV was integrated to the experiment group peripheral venous catheters. Catheters were observed for 72 hours in terms of complications such as bleeding, leakage, and phlebitis infiltration. Catheters were removed for culture sampling 72 hours after catheterization. Descriptive statistics and Pearson chi-square were used in the analysis of the data. Results: The rate of colonization was 5.6% in 3WSCs and 2.8% in SSIVs. When the colonization rates were compared, there was no statistically significant difference between 3WSCs and SSIVs about catheter colonization and infection (p>0.05). Conclusion: Both connectors can be used safely in the administration of continuous intravenous solution and drug therapy. Development of continuous in-service training programs for the prevention of catheter related blood system infections are suggested.
Keywords: Catheter-related infections; peripheral venous catheterization; catheter care
Amaç: Konnektörler, intravenöz sıvı tedavisi alan hastalarda sıklıkla ve zorunlu olarak kullanılır. Aseptik teknikler kullanılmazsa, tüm kateterler ve konektörler kateter enfeksiyonları için bir risk faktörü olabilir. Bu çalışma, 3 yollu musluk [3-way stopcock (3WSC)] ve split septumlu enjeksiyon valfinin [Split Septum Injection Valve (SSIV)] periferik intravenöz kateter kolonizasyonu ve enfeksiyonu üzerindeki etkisini belirlemek amacıyla yapılmıştır. Gereç ve Yöntemler: Araştırma, yarı deneysel bir çalışmadır. Araştırmanın örneklemini 216 (108 kontrol ve 108 deney grubu) hasta oluşturmaktadır. Kontrol grubuna 3WSC, deney grubu periferik venöz kateterlere SSIV takılmıştır. Kateterler kanama, sızıntı, flebit, infiltrasyon gibi komplikasyonlar açısından 72 saat gözlemlenmiştir. Kateterizasyondan 72 saat sonra kültür örneklemesi için kateterler çıkarıldı. Verilerin analizinde, tanımlayıcı istatistikler ve Pearson ki-kare kullanılmıştır. Bulgular: Kolonizasyon oranı 3WSC'lerde %5,6 ve SSIV'lerde %2,8 idi. Kolonizasyon oranları karşılaştırıldığında, 3WSC'ler ve SSIV'ler arasında kateter kolonizasyonu ve enfeksiyonu açısından istatistiksel olarak anlamlı bir fark yoktu (p>0,05). Sonuç: Her iki konnektör de sürekli intravenöz solüsyon uygulamasında ve ilaç tedavisinde güvenle kullanılabilir. Kateter ilişkili kan dolaşımı enfeksiyonlarının önlenmesi için sürekli hizmet içi eğitim programlarının geliştirilmesi önerilmektedir.
Anahtar Kelimeler: Kateter ilişkili enfeksiyonlar; periferik venöz kateterizasyon; kateter bakımı
- O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162-93. [Crossref] [PubMed] [PMC]
- Yébenes JC, Serra-Prat M. Clinical use of disinfectable needle-free connectors. Am J Infect Control. 2008;36(10):S175.e1-4. [Crossref] [PubMed]
- Marsh N, Webster J, Mihala G, Rickard CM. Devices and dressings to secure peripheral venous catheters to prevent complications. Cochrane Database Syst Rev. 2015;(6):CD011070. [Crossref] [PubMed]
- Chernecky C, Macklin D. The role of IV needleless connectors and IV complication management and prevention. Advances in Research. 2014;2:195-206. [Crossref]
- Buehrle DC. A prospective, randomized comparison of three needleless IV systems used in conjunction with peripherally inserted central catheters. J Vasc Access. 2004;9(1):35-8. [Crossref]
- Türk Hastane İnfeksiyonları ve Kontrolü Derneği. Ulusal Damar Erişimi Yönetimi Rehberi 2019 [National Vascular Access Management Guideline 2019]. The Journal of Hospital Infections. 2019;23(1):1-54. [Link]
- Loveday HP, Wilson JA, Pratt RJ, Golsorkhi M, Tingle A, Bak A, et al. epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2014;86 Suppl 1:S1-70. [Crossref] [PubMed] [PMC]
- Rosenthal VD. Impact of needle-free connectors compared with 3-way stopcocks on catheter-related bloodstream infection rates: A meta-analysis. Am J Infect Control. 2020;48(3):281-4. Erratum in: Am J Infect Control. 2021;49(1):136. [Crossref] [PubMed]
- Luna J, Masdeu G, Pérez M, Claramonte R, Forcadell I, Barrachina F, et al. Clinical trial evaluating a new hub device designed to prevent catheter-related sepsis. Eur J Clin Microbiol Infect Dis. 2000;19(9):655-62. [Crossref] [PubMed]
- Oto J, Nishimura M, Morimatsu H, Katayama H, Onodera M, Takahashi H, et al. Comparison of contamination between conventional three-way stopcock and needleless injection device: a randomized controlled trial. Med Sci Monit. 2007;13(10):CR417-21. [PubMed]
- Sengul T, Guven B, Ocakci AF, Kaya N. Connectors as a risk factor for blood-associated infections (3-way stopcock and needleless connector): A randomized-experimental study. Am J Infect Control. 2020;48(3):275-80. [Crossref] [PubMed]
- Bouza E, Mu-oz P, López-Rodríguez J, Jesús Pérez M, Rincón C, Martín Rabadán P, et al. A needleless closed system device (CLAVE) protects from intravascular catheter tip and hub colonization: a prospective randomized study. J Hosp Infect. 2003;54(4):279-87. [Crossref] [PubMed]
- Niël-Weise BS, Daha TJ, van den Broek PJ. Is there evidence for recommending needleless closed catheter access systems in guidelines? A systematic review of randomized controlled trials. J Hosp Infect. 2006;62(4):406-13. [Crossref] [PubMed]
- Casey AL, Burnell S, Whinn H, Worthington T, Faroqui MH, Elliott TS. A prospective clinical trial to evaluate the microbial barrier of a needleless connector. J Hosp Infect. 2007;65(3):212-8. [Crossref] [PubMed]
- Rosenthal VD. Clinical impact of needle-free connector design: a systematic review of literature. J Vasc Access. 2020;21(6):847-53. [Crossref] [PubMed]
- Moureau NL, Flynn J. Disinfection of needleless connector hubs: clinical evidence systematic review. Nurs Res Pract. 2015;2015:796762. [Crossref] [PubMed] [PMC]
- Hadaway L. Needleless connectors: improving practice, reducing risks. Journal of the Association for Vascular Access. 2011;16(1):20-33. [Crossref]
- Pohl F, Hartmann W, Holzmann T, Gensicke S, Kölbl O, Hautmann MG. Risk of infection due to medical interventions via central venous catheters or implantable venous access port systems at the middle port of a three-way cock: luer lock cap vs. luer access split septum system (Q-Syte). BMC Infect Dis. 2014;14:41. [Crossref] [PubMed] [PMC]
- Küçüker I. İntravenöz uygulamalarda üç yollu musluk ile iğnesiz enjeksiyon valfi kullanımının enfeksiyon gelişimine etkisinin karşılaştırılması [Yüksek lisans tezi]. İstanbul: Marmara Üniversitesi; 2011. [Link]
- Rosenthal VD, Udwadia FE, Kumar S, Poojary A, Sankar R, Orellano PW, et al. Clinical impact and cost-effectiveness of split-septum and single-use prefilled flushing device vs 3-way stopcock on central line-associated bloodstream infection rates in India: a randomized clinical trial conducted by the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control. 2015;43(10):1040-5. [Crossref] [PubMed]
- González López JL, Arribi Vilela A, Fernández del Palacio E, Olivares Corral J, Benedicto Martí C, Herrera Portal P. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117-26. [Crossref] [PubMed]
- Juhlin D, Hammarskjöld F, Mernelius S, Taxbro K, Berg S. Microbiological colonization of peripheral venous catheters: a prospective observational study in a Swedish county hospital. Infect Prev Pract. 2021;3(3):100152. [Crossref] [PubMed] [PMC]
.: Process List